Medicine and Dentistry
Assessment
100%
Patient
82%
Therapeutic Procedure
69%
Microcirculation
64%
Calcium Sensing Receptor
62%
Inpatient
58%
Nitrosourea
57%
Cornea
52%
Mutant
46%
Hypercalcaemia
42%
Corneal Dystrophy
41%
Hypocalcaemia
38%
Autosomal Dominant Inheritance
36%
Bone
32%
Parathyroid Hormone
30%
Disease
29%
Eye Disease
27%
Cardiovascular Disease
25%
Family
24%
Hyperglycemia
24%
Severe Acute Respiratory Syndrome Coronavirus 2
22%
Screening
22%
Omicron Coronavirus Variant
21%
Coronary Artery Disease
20%
Corneal Epithelium
20%
Adult
18%
COVID-19 Vaccine
18%
Myocardial Infarction
18%
Observational Study
18%
Coronary Microvascular Dysfunction
18%
Suture Material
18%
Glucocorticoid
18%
Signal Transduction
18%
Programmed Cell Death
18%
Corticotropin Releasing Factor
18%
Acute Heart Infarction
18%
Biological Marker
18%
Microangiopathy
18%
Kinase Signaling
18%
Nanoparticle
18%
Cushing Syndrome
18%
Peptide Receptor
18%
Microvessel
16%
Male
16%
In Vitro
15%
Isotopes of Calcium
13%
Conjunctiva
12%
Corticotropin
12%
Guide RNA
12%
Osteoblast
12%
Biochemistry, Genetics and Molecular Biology
Protein
91%
Transforming Growth Factor Beta Induced
76%
Hypocalcaemia
75%
Calcium-Sensing Receptor
54%
Hypercalcaemia
54%
CRISPR/Cas9
49%
Wild Type
48%
Gene
47%
Allele
47%
Genome Editing
42%
G Protein
41%
Phenotype
41%
Proband
39%
Mouse Model
33%
Codon
27%
Protospacer Adjacent Motif
24%
Apoptosis
24%
Regulatory Mechanism
23%
Genetics
21%
DNA
21%
Sample
21%
Signal Transduction
20%
CRISPR
20%
Single-Nucleotide Polymorphism
18%
Protein Characterization
18%
Guide RNA
18%
Mitogen-Activated Protein Kinase
18%
Capsid
18%
Adeno Associated Virus Vector
18%
AP2S1
18%
Natriuretic Peptide
18%
Gene Silencing
18%
RNA Interference
18%
Keratin
18%
DNA Cleavage
18%
Small Interfering RNA
18%
Cooperation
18%
Genome Sequencing
18%
Spectrum
18%
Loss of Function Mutation
18%
Phosphorylation
18%
Unfolded Protein Response
18%
Adeno Associated Virus
18%
Genetic Divergence
15%
Germline
12%
Human Genome
12%
Cell Proliferation
12%
S Cell
12%
Cas9
11%
Non-Homologous End Joining
11%